A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions
This study is designed to assess whether consumers select and use ella® (ulipristal acetate
30mg), an emergency contraceptive, in a manner consistent with the OTC package directions in
an OTC-like setting.
This trial will assess the efficacy and safety of PGL4001 versus GnRH agonist, over a
3-month period for the pre-operative treatment of pre-menopausal women suffering from
excessive uterine bleeding due to uterine myoma.
This trial will assess the efficacy and safety of PGL4001 with concomitant iron
administration versus placebo with concomitant iron administration, over a 3-month period
for the pre-operative treatment of pre-menopausal women suffering from excessive uterine
bleeding due to uterine myoma.
Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women
The purpose of this observational study is to assess the safety and tolerability of ellaOne®
in routine conditions of use for emergency contraception in postmenarcheal adolescents and
adult women who want to prevent pregnancy up to 5 days after unprotected sexual intercourse.
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
This is a multicentre, Phase III, efficacy and safety open-label study with PGL4001 10mg
once daily for 3 months, blinded towards the administration of progestin or placebo after
end of PGL4001 treatment.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.